A month after a sickle cell pain crisis, columnist Dunstan Nicol-Wilson is learning how to trust his body again, which isn't easy.

The gene-editing therapy OTQ923 normalized brain blood flow in 3 sickle cell disease patients, suggesting it may lower stroke ...

As a result of being a caregiver for her cousin, columnist Sylvia Amuta says she's now more caring, compassionate, and kind ...

The first healthy volunteer has been dosed in a Phase 1 study of Cellarity's novel globin-switching therapy CLY-124 for ...

Higher pain scores upon discharge from the emergency department may predict hospitalization in adolescents with SCD, a study ...

The first healthy volunteer has been dosed in a Phase 1 study of Cellarity's novel globin-switching therapy CLY-124 for sickle cell disease.

Considering a change to your treatment regimen? Columnist Mary Shaniqua shares tips to help patients and providers make an informed decision.

Most people with SCD seem to meet or exceed current level of physical activity recommendations for the general population, a study shows.